scholarly journals PENGARUH TEKNIK RELAKSASI OTOT PROGRESIF TERHADAP PENURUNAN KADAR GULA DARAH PADA PASIEN DIABETES MELLITUS TIPE 2 DI RUMAH SAKIT GRANDMED LUBUK PAKAM

2019 ◽  
Vol 1 (2) ◽  
pp. 48-53
Author(s):  
Tati Murni Karokaro ◽  
Muhammad Riduan

The prevalence of diabetes occuring in 2015 is 9,3% and is expected to increase annualy. Type 2 diabetes mellitus occurs because insulin resistance, which glucose fails to enter the cell, usually occurs in the age above 30 years. One of the modalitas therapy that can be done is progressive muscle relaxation. The purpose of the study was to the identify the effect of progressive muscle relaxation therapy on the decrease in blood sugar levels in patients with type 2 diabetes mellitus at hospital GRANDMED Lubuk Pakam. This research method used pre-experimental design with one group pretest-posttest. A sample size of 10 respondents selected by sampling technique of non-probability sampling type consecutive sampling. The result of paired hypothesis test of t-test sample at significance level 95%obtained p Value < α, that is 0,001 indicates that there is influence of progressive muscle relaxation therapy to decrease blood glucose level in type 2 diabetes mellitus patient. Conclusion obtained there is significant difference between blood glucose levels before and after progressive muscle relaxation therapy. It is sugessted that health care institutions need to implement new policies related to the application of progressive muscle relaxation therapy.

2021 ◽  
Vol 17 (1) ◽  
Author(s):  
Yonghuan Bian ◽  
Changhao Liu ◽  
Zhaojiang Fu

Abstract Background Our study attempted to observe the value of periodontal curettage combined with root planing on moderate-to-severe chronic periodontitis in patients with type 2 diabetes. Methods There involved 72 patients with type 2 diabetes mellitus complicated with moderate-to-severe chronic periodontitis who were diagnosed and treated in our hospital from January 2019 to December 2019. The patients enrolled were randomly divided into four groups using a computer-generated table: root planing and periodontal curettage combined group (n = 18), root planning group (n = 18), periodontal curettage group (n = 18) and cleansing group (n = 18). Blood glucose, plaque index (PI), gingival index (GI), probing depth (PD), attachment loss (AL), serum levels of inflammatory factors (Tumor Necrosis Factor Alpha [TNF- α] and hypersensitive C-reactive protein [hs-CRP]) were observed before and after treatment. The collecting dates were analyzed by the chi-square χ 2 test, repeated measurement analysis of variance, or t-test according to different data types and research objectives. Results Before treatment, there was no significant difference in PI, GI, PD and AL among the four groups (P> 0.05), while after 3-month treatment, the levels of PI, GI, PD and AL in the combined group were lower than those in the root planing group, periodontal curettage group and cleansing group, with both root planing group and periodontal curettage group significantly lower than cleansing group (P< 0.05). The fasting blood glucose, 2-h postprandial blood glucose and glycosylated hemoglobin in the combined group, root planing group, periodontal curettage group and cleansing group were significantly lower than those before treatment (P < 0.05). Before treatment, there was no significant difference in TNF- α and hs-CRP among the four groups (P> 0.05), but the levels of TNF- α and hs-CRP in the four groups decreased significantly after 3-month treatment (P< 0.05). The levels of TNF- α and hs-CRP in the combined group were lower than those in the root planing group, periodontal curettage group and cleansing group, and those in the root planing group and periodontal curettage group were significantly lower than those in the cleansing group (P< 0.05). Conclusion The combination therapy of periodontal curettage and root planing exerted beneficial effects on moderate-to-severe chronic periodontitis in patients with type 2 diabetes mellitus, which holds the potential to maintain the level of blood glucose and improve the quality of life of the patients.


2019 ◽  
Vol 2019 ◽  
pp. 1-7 ◽  
Author(s):  
Huiqin Li ◽  
Xiaohua Xu ◽  
Jie Wang ◽  
Xiaocen Kong ◽  
Maoyuan Chen ◽  
...  

Objective. To evaluate the effects of once-weekly dulaglutide injection and once-daily glimepiride on glucose fluctuation in patients with type 2 diabetes mellitus (T2DM) using the Continuous Glucose Monitoring System (CGMS). Methods. A total of 23 patients with T2DM were randomly assigned into two groups for 26 weeks: the dulaglutide group (n=13) and the glimepiride group (n=10). 72-hour CGMS was applied to all patients: before and after the treatment. General clinical data were collected and measured, such as fasting blood glucose (FBG), glycosylated hemoglobin (HbA1c), tumor necrosis factor-α (TNF-α), 8-iso-prostaglandin F2α (8-iso-PGF2α), and interleukin-6 (IL-6). Results. HbA1c of the dulaglutide group was reduced from 8.38±0.93% to 6.68±0.73% after the treatment (P<0.05); similarly, it was reduced from 7.91±0.98% to 6.67±0.74% (P<0.05) in the glimepiride group. The levels of serum 8-iso-PGF2α, TNF-α, and IL-6 all decreased significantly in both groups after treatment, and there was no significant difference found between the two groups (P>0.05). The Mean Blood Glucose (MBG) of the two groups declined significantly after therapy (P<0.05). However, the Standard Deviation of Blood Glucose (SDBG) decreased significantly only in the dulaglutide group (from 2.57±0.74 mmol/L to 1.98±0.74 mmol/L, P<0.05). There were no significant changes of Mean Amplitude of Glycemic Excursion (MAGE) and Absolute Means of Daily Difference (MODD) after treatment in both groups. Furthermore, no statistically significant difference was found between the two groups in MBG, SDBG, MAGE, and MODD (P>0.05). The percentage time (PT) (>10 mmol/L and 3.9-10 mmol/L) of the two groups was significantly changed after the treatment (P<0.05). However, this was not seen in the PT<3.9 mmol/L after the treatment (P>0.05). Conclusion. Once-weekly dulaglutide injection has the same effectiveness as daily glimepiride on lowering blood glucose and decreasing oxidation stress and inflammation and is more effective in controlling glucose fluctuation as compared with glimepiride. This trial is registered with ClinicalTrials.gov NCT01644500.


2018 ◽  
Vol 2018 ◽  
pp. 1-9 ◽  
Author(s):  
Mengyao Chao ◽  
Chunyan Wang ◽  
Xiaosheng Dong ◽  
Meng Ding

Objective. To investigate the effects of Tai chi in type 2 diabetes mellitus (type-2 DM) patients using systematic review and meta-analysis. Methods. Seven electronic resource databases were searched, and randomized controlled trials on the role of Tai chi in type-2 DM patients were retrieved. The meta-analysis was performed with RevMan 5.3, and research quality evaluation was conducted with the modified Jadad scale. Results. Fourteen studies, with 798 individuals related to the intervention of Tai chi on diabetes, were included. The results showed that, compared with nonexercise, Tai chi had the effect of lowering fasting blood glucose [MD = −1.39, 95% CI (−1.95, −0.84), P<0.0001] and the subgroup effect size decreased with the increase of total exercise amount, there is no significant difference between Tai chi and other aerobic exercises [MD = −0.50, 95% CI (−1.02, 0.02), P=0.06]; compared with nonexercise, Tai chi could reduce HbA1c [MD = −0.21, 95% CI (−0.61, 0.19), P=0.31], and the group effect size decreased with the increase of total exercise amount. The reducing HbA1c effect of Tai chi was better than that of other aerobic exercises, but the difference was at the margin of statistical significance [MD = −0.19, 95% CI (−0.37, 0.00), P=0.05]; compared with nonexercise, Tai chi had the effect of reducing 2 h postprandial blood glucose [MD = −2.07, 95% CI (−2.89, −1.26), P=0.0002], there is no significant difference between Tai chi and other aerobic exercises in reducing 2 h postprandial blood glucose [MD = −0.44, 95% CI (−1.42, 0.54), P=0.38]. Conclusion. Tai chi can effectively affect the management of blood glucose and HbA1c in type-2 DM patients. Long-term adherence to Tai chi has a better role in reducing blood glucose and HbA1c levels in type 2 DM patients.


2018 ◽  
Vol 2 (1) ◽  
pp. 45
Author(s):  
Adbul Rokhman ◽  
Lilik Supriati

ABSTRAKPenyakit diabetes mellitus yang tidak bisa disembuhkan secara total sering berdampak pada terjadinya kecemasan dan penurunan kualitas hidup. Untuk menurunkan kecemasan dan meningkatkan kualitas hidup pasien dapat dilakukan terapi progressive muscle relaxation. Penelitian ini bertujuan untuk mengetahui pengaruh terapi PMR (Progressive Muscle Relaxation) terhadap kecemasan dan kualitas hidup pada pasien diabetes mellitus tipe 2 di RS Muhammadiyah Lamongan. Metode quasi eksperimental dengan pendekatan pre-post test control group design dengan simple random sampling. Jumlah sampel 50 orang dibagi menjadi 2 kelompok perlakuan dan kontrol masing-masing 25 orang. Alat ukur menggunakan kuisioner HARS untuk kecemasan dan DQOL (Diabetes Quality of Life) untuk kualitas hidup. Hasil analisis kecemasan dengan uji t pada kelompok perlakuan p 0,000, kelompok kontrol p 0,746. Analisis kualitas hidup pada kelompok perlakuan nilai p 0,000 dan kelompok kontrol p 0,098. Perbedaan kecemasan pada kelompok perlakuan dan kontrol p 0,019. Perbedaan kualitas hidup pada kelompok perlakuan dan kontrol p 0,076. Pengaruh faktor pendidikan terhadap kualitas hidup pada pasien DM tipe 2 sesudah diberikan terapi progressive muscle relaxation sebesar 4,9 % setelah dikontrol variabel lain. Terapi progressive muscle relaxation efektif untuk menurunkan kecemasan dan efektif untuk meningkatkan kualitas hidup pasien DM tipe 2. Terapi progressive muscle relaxation dapat dimasukkan kedalam intervensi keperawatan pada pelayanan rumah sakit. Kata Kunci: Diabetes Mellitus tipe 2, Kecemasan, Kualitas Hidup, Terapi Progressive Muscle Relaxation ABSTRACTDiabetes mellitus which cannot be cured completely often have an impact on the occurrence of anxiety and reduced quality of life. To reduce anxiety and improve the quality of life of patients can use progressive muscle relaxation therapy. This study aims to determine the effect of PMR therapy (Progressive Muscle Relaxation) in anxiety and quality of life in patients with type 2 diabetes mellitus in Lamongan Muhammadiyah Hospital. Quasi-experimental method with the approach of pre-posttest control group design with simple random sampling. Number of samples 50  people  were   divided  into   two   treatment   groups  and   control  each   25   people.  HARS questionnaire instrument used for measuring anxiety and DQOL (Diabetes Quality of Life) for measuring quality of life. Results of the analysis by the t-test anxiety in the experimental group p0.000, 0.746 p control group. Analysis of the quality of life in the treatment group p values of 0.000 and 0.098 p control group. Anxiety differences in the treatment group and the control p0.019. Differences in the quality of life in the treatment group and the control p 0.076. Results of the analysis by the t-test anxiety in the experimental group p 0.000, 0.746 p control group. Analysis of the quality of life in the treatment group p values of 0.000 and 0.098 p control group. Anxiety differences in the treatment group and the control p 0.019. Differences in the quality of life in the treatment group and the control p 0.076. Educational factors influence the quality of life in patients with type 2 diabetes mellitus after progressive muscle relaxation therapy by 4.9% after controlling other variables. Progressive muscle relaxation therapy is effective to reduce anxiety and effective to improve the quality of life of patients with type 2 diabetes. Progressive muscle relaxation therapy can be incorporated into nursing interventions on hospitals.Keyword : Type 2 Diabetes Mellitus, anxiety, quality of life, progressive muscle relaxation therapy


2021 ◽  
Author(s):  
Yimeng Ge ◽  
Sanbao Chai ◽  
Yu Wan ◽  
Huaqin Xia ◽  
Ruilan Dong ◽  
...  

Abstract Purpose To determine the impact of type 2 diabetes mellitus (T2DM) on visual functions, identify different modifiers as risk or protective factors, and find out how these factors affect patients’ visual symptoms and vision-related quality of life as a whole. Methods We performed an online survey among 1242 participants (400 patients, 842 non-patients). Demographic features and severity of disease were documented, while visual functions were evaluated using National Eye Institute Visual Functioning questionnaire-25 (NEI VFQ-25). Independent t-test, analysis of variance, linear and non-linear regression models were used to assess all data. Results Scores other than color vision among T2DM patients were significantly lower compared with non-T2DM participants. There was significant difference after stratification of age and education, but no significant difference between different genders was observed. Parameters including duration of T2DM, fasting plasma glucose (FPG) and glycosylated hemoglobin A1c (HbA1c) negatively impacted on the scores, with 20 years’ of diabetic duration, 10mmol/L of FPG, 7.5% of HbA1c being potential cut-off points. Poorer best corrected visual acuity (BCVA) and diagnosis of diabetic retinopathy were risk factors, while they simultaneously produced mediation effect, contributing 5%-78% of effect in the deterioration of visual functions caused by longer diabetic duration and higher blood glucose. Conclusion Significant visual impairments and faster deterioration in visual functions were seen in T2DM patients, with older age, lower educational level, longer diabetic duration, poorer blood glucose administration, limited BCVA, and the presence of diabetic retinopathy identified as risk factors. Average BCVA and diabetic retinopathy also yielded mediation effect as diabetic duration lengthened and blood glucose elevated.


Author(s):  
Muhammad Gandhi Sastrawan ◽  
Hasan Sjahrir ◽  
Kiki Mohammad Iqbal

Background: Deleterious effects of diabetic glucose levels on brain structure, have been reported in many studies. Moreover, prediabetic and type-2 diabetes mellitus are associated with lower cognitive function. Author aimed to discover the association of blood glucose and working memory on type 2 diabetic and prediabetic patients.Methods: In this cross-sectional study there are two groups (diabetic and prediabetic) consist of 30 patients each (men 31, women 29). Mean age 40.233±7.862. Blood glucose was measured with HbA1c. All patients were tested with MMSE (Mini Mental State Examination), forward digit span, and backward digit span.Results: There was no difference between diabetic and prediabetic group in MMSE (p 1.000). In diabetic group, mean LDSF (Longest Digit Span Forward) was 5.700±0.877 and there was relation between HbA1c and LDSF (r -0.604). In prediabetic group, mean LDSF was 6.233±0.858 and there was relation between HbA1c and LDSF (r -0.565). There was significant difference between those groups in LDSF (p 0.041). In diabetic group mean LDSB (Longest Digit Span Backward) was 3.767±0.817 and there was relation between HbA1c and LDSB (r -0.545). In prediabetic group, mean LDSB was 4.300±0.750 and there was relation between HbA1c and LDSB (r -0.575). There was significant difference between those groups in LDSB (p 0.024).Conclusions: Results indicated that there was significant difference between diabetic and prediabetic patient in working memory test although there was no difference in general cognitive function.


2019 ◽  
Vol 2019 ◽  
pp. 1-8
Author(s):  
Xin Zhao ◽  
Xiaofeng Yu ◽  
Xiaomei Zhang

Aims. To investigate the effect of peer support education model on the levels of glucose and lipids in patients with type 2 diabetes mellitus in China. Methods. 120 type 2 diabetes mellitus patients (T2DM) were assigned to two groups randomly from December 2016 to October 2017. Group 1 was trained on basic diabetic medical knowledge by a professional medical staff. After 8 weeks of studying, these specially trained patients then trained the patients of Group 2. Results. It was found that after 3 months of intervention, the levels of fasting blood glucose, triglycerides, glycosylated hemoglobin, total cholesterol, and low-density lipoprotein cholesterol were significantly decreased for the two groups (p<0.05). However, with the prolongation of time, there were no significant changes in the two groups in the above indices (p>0.05) after 6 months, and the result was the same after strafing sex, age, and education level. Meanwhile, there was no significant difference in decreasing glucose and lipid level between the two groups’ participants (p>0.05). Conclusion. It was found that both the peer support education model and medical staff education model have a better short-term effect on blood glucose and lipid levels in patients with type 2 diabetes. As there is no difference of effect between the two methods of training, the peer support education model can be widely used in diabetes education.


Epigenomics ◽  
2021 ◽  
Author(s):  
Marwa Matboli ◽  
Doaa Ibrahim ◽  
Amany H Hasanin ◽  
Mohamed Kamel Hassan ◽  
Eman K Habib ◽  
...  

Aim: To assess isorhamnetin efficacy for diabetic kidney disease in a Type 2 diabetes mellitus rat model, through investigating its effect at the epigenetic, mRNA and protein levels. Materials & methods: Type 2 diabetes mellitus was induced in rats by streptozotocin and high-fat diet. Rats were treated with isorhamnetin (50 mg/kg/d) for 4 or 8 weeks. Fasting blood glucose, renal and lipid profiles were evaluated. Renal tissues were examined by light and electron microscopy. Autophagy genes ( FYCO1, ULK, TECPR1 and  WIPI2) and miR-15b, miR-34a and miR-633 were assessed by qRT-PCR, and LC3A/B by immunoblotting. Results: Isorhamnetin improved fasting blood glucose, renal and lipid profiles with increased autophagosomes in renal tissues. It suppressed miRNA regulation of autophagy genes Conclusion: We propose a molecular mechanism for the isorhamnetin renoprotective effect by modulation of autophagy epigenetic regulators.


2019 ◽  
Vol 5 (1) ◽  
Author(s):  
Musri Musman ◽  
Mauli Zakia ◽  
Ratu Fazlia Inda Rahmayani ◽  
Erlidawati Erlidawati ◽  
Safrida Safrida

Abstract Background Ethnobotany knowledge in a community has shaped local wisdom in utilizing plants to treat diseases, such as the use of Malaka (Phyllanthus emblica) flesh to treat type 2 diabetes. This study presented evidence that the phenolic extract of the Malaka flesh could reduce blood sugar levels in the diabetic induced rats. Methods The phenolic extract of the P. emblica was administrated to the glucose-induced rats of the Wistar strain Rattus norvegicus for 14 days of treatment where the Metformin was used as a positive control. The data generated were analyzed by the two-way ANOVA Software related to the blood glucose level and by SAS Software related to the histopathological studies at a significant 95% confidence. Results The phenolic extract with concentrations of 100 and 200 mg/kg body weight could reduce blood glucose levels in diabetic rats. The post hoc Dunnet test showed that the administration of the extract to the rats with a concentration of 100 mg/kg body weight demonstrated a very significant decrease in blood glucose levels and repaired damaged cells better than administering the extract at a concentration of 200 mg/kg weight body. Conclusion The evidence indicated that the phenolic extract of the Malaka flesh can be utilized as anti type 2 Diabetes mellitus without damaging other organs.


2021 ◽  
Vol 28 (Supplement_1) ◽  
Author(s):  
F Ahmadizar ◽  
K Wang ◽  
F Mattace Raso ◽  
MA Ikram ◽  
M Kavousi

Abstract Funding Acknowledgements Type of funding sources: None. Background. Arterial stiffness/remodeling results in impaired blood flow and, eventually, decreased glucose disposal in peripheral tissues and increased blood glucose. Besides, increased arterial stiffness/remodeling may lead to hypertension, as a potential reciprocal risk factor for type 2 diabetes mellitus (T2D). We, therefore, hypothesized that increased arterial stiffness/remodeling is associated with an increased risk of T2D. Purpose. To study the associations between arterial stiffness/remodeling and incident T2D. Methods. We used the prospective population-based Rotterdam Study. Common carotid arterial properties were ultrasonically determined in plaque-free areas. Aortic stiffness was estimated by carotid-femoral pulse wave velocity (cf_PWV), carotid stiffness was estimated by the carotid distensibility coefficient (carDC). Arterial remodeling was estimated by carotid artery lumen diameter (carDi), carotid intima-media thickness (cIMT), mean circumferential wall stress (CWSmean), and pulsatile circumferential wall stress (CWSpuls). Cox proportional hazard regression analysis was used to estimate the associations between arterial stiffness/remodeling and the risk of incident T2D, adjusted for age, sex, cohort, mean arterial pressure (MAP), antihypertensive medications, heart rate, non- high-density lipoprotein (HDL)-cholesterol, lipid-lowering medications, and smoking. We included interaction terms in the fully adjusted models to study whether any significant associations were modified by sex, age, blood glucose, or MAP. Spearman correlation analyses were applied to examine the correlations between measurements of arterial stiffness/remodeling and glycemic traits. Results. We included 3,055 individuals free of T2D at baseline (mean (SD) age, 67.2 (7.9) years). During a median follow-up of 14.0 years, 395 (12.9%) T2D occurred. After adjustments, higher cf_PWV (hazard ratio (HR),1.18; 95%CI:1.04-1.35), carDi (1.17; 1.04-1.32), cIMT (1.15; 1.01-1.32), and CWSpuls (1.28; 1.12-1.47) were associated with increased risk of incident T2D. After further adjustment for the baseline glucose, the associations attenuated but remained statistically significant. Sex, age, blood glucose, or MAP did not modify the associations between measurements of arterial stiffness/remodeling, and incident T2D. Among the population with prediabetes at baseline (n = 513) compared to the general population, larger cIMT was associated with a greater increase in the risk of T2D. Most measurements of arterial stiffness/remodeling significantly but weakly correlated with baseline glycemic traits, particularly with blood glucose.  Conclusions. Our study suggests that greater arterial stiffness/remodeling is independently associated with an increased risk of T2D development. Blood glucose and hypertension do not seem to play significant roles in these associations. Further studies should disentangle the underlying mechanism that links arterial stiffness/remodeling and T2D.


Sign in / Sign up

Export Citation Format

Share Document